[193 Pages Report] The Women's Health Market size was estimated at USD 43.23 billion in 2023 and expected to reach USD 46.99 billion in 2024, at a CAGR 8.97% to reach USD 78.90 billion by 2030.
The women's health market includes diagnosis, treatments, medications, surgical procedures, and preventative measures for female-related disorders and diseases. The women's health market focuses on improving disease management and enhancing the general health of the female population. The surging prevalence of hormonal disorders, osteoporosis, anemia, and breast cancer among women have raised the need for adequate diagnosis and appropriate treatment to improve women's health globally. The growing awareness regarding self-healthcare and the availability of women's health products, including multivitamins and protein supplements, is accelerating sales of women's health products and supplements. However, the high cost associated with treating certain female diseases, including breast cancer, may prevent the female population from availing of the treatment. Additionally, the rising research and development (R&D) and the initiatives implemented by governments worldwide to raise awareness regarding early diagnosis of female diseases and to improve women's health are expected to create significant potential to expand the use of women's health products and may propel women to avail for medical treatments to treat the underlying medical conditions.
The women's health market in the Americas region is highly developed and is attributed to the rising number of female disorders and increasing awareness regarding self-healthcare among women in the region. The governments of the developed and emerging economies, including the U.S., U.K, Australia, Brazil, Canada, India, China, Japan, Germany, and France, among others, are taking initiatives to spread awareness regarding women's diseases and to improve health o the female population across their respective nations. For instance, the Department of Health in Australia launched the National Women's Health Strategy 2020 to 2030 to improve the health and well-being of all women in Australia, especially those at risk of poor health. Asian countries, including South Korea and Japan, are considerably producing various women's health supplements that contain Vitamin E & C, Vitamin B12, marine collagen, protein, and other natural ingredients that can assist women in improving their overall health. Additionally, the rising approval of women's health medications, including those for hormonal disorders and contraceptive pills, and the increasing commercialization of these products are expected to proliferate the use of women's health products.
The market dynamics represent an ever-changing landscape of the Women's Health Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
- Market Drivers
- Increasing cases of hormonal imbalances and chronic diseases in women
- Rising trend of superfood and increasing availability of multivitamins for women
- Inclination of women towards natural and plant based health supplements
- Market Restraints
- High cost of clinical treatments
- Market Opportunities
- Rising R&D activities for drug development to treat the hormonal disorders
- Favorable policies initiated by governments worlwide to improve women’s health
- Market Challenges
- Side-effects associated with consumption of drugs
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Women's Health Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Women's Health Market.
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Women's Health Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
The value chain of the Women's Health Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.
The pricing analysis comprehensively evaluates how a product or service is priced within the Women's Health Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Women's Health Market.
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Women's Health Market.
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Women's Health Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.
The trade analysis of the Women's Health Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.
The regulatory framework analysis for the Women's Health Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Women's Health Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Women's Health Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Women's health startup Iron Health launches with $4.5M.
As the world of healthcare continues to become increasingly digitized, women’s health has seen unprecedented investment recently with the launch of Iron Health – a startup devoted exclusively to women’s health. The company recently announced a $45 million Series A funding round whose primary purpose is to foster innovation that empowers and propels progress at a high-level within the space of women’s specialized healthcare. The online platform seeks to put power into the hands of women by providing better access to resources than ever before and evidence-based products that were previously unavailable beyond traditional methods. Iron Health is poised to revolutionize how women are able to safely and securely access their very best healthcare possibilities from anywhere in the world. [Published On: 2023-03-10]
Onsite Women’s Health and Volpara Health Announce National Partnership.
Onsite Women’s Health and Volpara Health are thrilled to announce a new national partnership that will revolutionize the world of women's health. With state-of-the-art technology, this new alliance provides tailored breast assessments and comprehensive breast health education for women everywhere. Through their collaboration, Onsite is able to reach more individuals than ever before with personalized evaluations and evidence-based care plans designed to help empower women with their healthcare decisions. Volpara is extremely proud of the work they are accomplishing together and both organizations look forward to transforming the way female health is approached in the years to come. [Published On: 2023-02-09]
Kiran Mazumdar Shaw invests in women’s health platform Gytree.com.
Women's health has become an important focus in the healthcare field. Investment from Kiran Mazumdar Shaw into the female-oriented health platform Gytree.com solidifies the message that women's health should be given attention and priority. Gytree.com provides support for a woman's distinct healthcare challenges, as well as tips and strategies to ensure her optimal wellbeing. The website also functions as a peer-to-peer communication tool, allowing women to connect with each other and share experiences regarding their healthcare journeys. Ms. Mazumdar Shaw could not have chosen a more relevant or impactful investment opportunity than Gytree.com; its goal of providing comprehensive, quality care to women ensures that every woman is empowered with the knowledge needed to make informed decisions about her own health and well-being. [Published On: 2023-01-11]
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Women's Health Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
The report delves into recent significant developments in the Women's Health Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, F. Hoffmann-La Roche Ltd., Gennev, Inc. by Unified Women's Healthcare, Ar-Ex Laboratories Pvt. Ltd., Siemens AG, TherapeuticsMD, Inc., Pregna International Ltd., Sysmex Asia Pacific Pte Ltd., Torrent Pharmaceuticals Ltd., Thermo Fisher Scientific Inc., Mankind Pharma Ltd., Alembic Pharmaceuticals Ltd., Cipla Limited, AstraZeneca PLC, Pfizer, Inc., Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Agile Therapeutics, Inc., Bharat Serums and Vaccines Ltd., Boston Imaging, Eli Lilly and Company, Amgen Inc., Serum Institute Of India Ltd., Novartis AG, Lupin Limited, Triglobal Lifesciences (opc) Pvt. Ltd., Mylan N.V. by Viatris, AbbVie Inc., GE HealthCare, The Himalaya Drug Company, Ferring B.V., Quest Diagnostics Incorporated, Mira by Quanovate Tech Inc., Apothecus Pharmaceutical Corp., AVA Sciences by FemTec Health Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Hologic, Inc..
This research report categorizes the Women's Health Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Age
- 13-17 Years
- 18-35 Years
- 36 Years & Above
- Distribution Channel
- Hospital
- Online
- Retail
- Application
- Contraceptives
- Endometriosis & Uterine Fibroids
- Hormonal Infertility
- Menopause
- Polycystic Ovary Syndrome
- Postmenopausal Osteoporosis
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Women's Health Market, by Age
- Women's Health Market, by Distribution Channel
- Women's Health Market, by Application
- Americas Women's Health Market
- Asia-Pacific Women's Health Market
- Europe, Middle East & Africa Women's Health Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 22]
- List of Tables [Total: 292]
- List of Companies Mentioned [Total: 38]
Superfoods are nutrient-dense foods that are enriched with essential minerals and vitamins that promote optimal health, known as packed with antioxidants, fiber, and power-packed nutrients that help combat many chronic illnesses. The interesting thing about superfoods is that they are not just limited but rather a category of foods that can be incorporated into meals. For example, many of us know that berries are superfoods, but so are leafy greens, nuts and seeds, fatty fish, and legumes. By incorporating these types of foods into daily diet, women can help improve their overall health and wellbeing.
When it comes to women's health, it is also important to consider taking multivitamins. This type of vitamin is specifically created for women and supports the unique nutritional needs of the female body. Multivitamins act as a safety net to catch any nutrients that may miss in daily diet. For instance, women need more calcium than men, making it challenging to get the right amount from the food to be consumed. By taking a multivitamin, women can get the recommended daily dose of calcium and other essential vitamins, promoting healthy hair, skin, and nails, regulating hormones, reducing stress levels, and strengthening bones.
In addition to being beneficial for women's health, superfoods and multivitamins have never been more accessible and affordable than they are today. It can be found easily in local supermarkets and online stores, making it easier to incorporate into daily diet. The good thing is, manufacturers are now offering healthier options. In the past, many multivitamins contained additives, preservatives, and sugar, which did more harm than good. However, thanks to educated consumers, manufacturers are now producing healthier options to cater to needs.
Another advantage of superfoods and multivitamins is that they are easy to incorporate into daily diets. Women don't need to spend hours preparing complicated meals to reap the benefits. For example, they can blend many superfoods, such as berries and leafy greens into a smoothie and take multivitamins with breakfast. Superfoods can also be used as toppings on yogurt, salads, or oatmeal to add flavor and nutrition.
It is important to prioritize women's health. Superfoods and multivitamins are an incredible way to promote health and wellbeing, but they aren't a cure-all. They act as a supplement to daily diets and should never be a substitute for a healthy and balanced meal plan. By incorporating these supplements into daily diets, women can enjoy the benefits of optimal health, improved energy, and overall wellbeing. So let's make a conscious effort to add superfoods and multivitamins into diets to promote optimal health and wellbeing.
- How big is the Women's Health Market?
- What is the Women's Health Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?